Financials

  • Market Capitalization 12.78 B
  • Employee 839
  • Founded 2015
  • CEO Neil Kumar
  • Website www.bridgebio.com
  • Headquarter Delaware, United States
  • FIGI BBG00P9KDZK6
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-20.24
市销率
29.18

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
711
SMMT
Summit Therapeutics Inc. - Common Stock
17.59 USD+2.45%+3.65%-2.66%-11.43%14.03 B USD
745
CORT
Corcept Therapeutics Incorporated - Common Stock
121.19 USD+2.24%+4.84%+6.89%+65.18%13.10 B USD
774
HALO
Halozyme Therapeutics, Inc. - Common Stock
110.42 USD+0.53%+0.70%+2.24%+65.30%12.53 B USD
829
TECH
Bio-Techne Corp - Common Stock
72.46 USD+0.01%+0.07%+0.35%+22.09%11.36 B USD

新闻